RU94015855A - QUINUCLIDINE DERIVATIVES, METHOD OF THEIR PRODUCTION, PHARMACEUTICAL COMPOSITION - Google Patents
QUINUCLIDINE DERIVATIVES, METHOD OF THEIR PRODUCTION, PHARMACEUTICAL COMPOSITIONInfo
- Publication number
- RU94015855A RU94015855A RU94015855/04A RU94015855A RU94015855A RU 94015855 A RU94015855 A RU 94015855A RU 94015855/04 A RU94015855/04 A RU 94015855/04A RU 94015855 A RU94015855 A RU 94015855A RU 94015855 A RU94015855 A RU 94015855A
- Authority
- RU
- Russia
- Prior art keywords
- derivatives
- denotes
- alkylcarbamoyl
- hydroxyl
- treatment
- Prior art date
Links
Claims (1)
в которой R1 обозначает водород или гидроксил; R2 - водород или R1 и R2 объединены вместе, так, что CR1 - CR2 обозначает двойную связь; Ar1 обозначает фенилен; Ar2 - 6- членный гетероарил, содержащий один или два атома азота; и где один из или оба Ar1 и Ar2 необязательно могут содержать один или более заместителей, таких, как галоген, гидроксил, амино, нитро, циано, карбоксил, карбомоил, алкил, алкенил, алкинил, алкоксил, алкиламино, диалкиламино, N - алкилкарбомоил, ди-N-N-алкилкарбамоил, алкоксикарбонил, алкилтио, алкилсульфинил, алкилсульфонил, галогеноалкил, алканоиламино, алкилендиокси, алканоил и его оксимные производные и простые O-алкиловые эфиры вышеуказанных оксимных производных; ингибируют скваленсинтазу и поэтому пригодны для лечения заболеваний и состояний, которые нужно лечить, где желательно ингибирование скваленсинтазы, например, для лечения гиперхолестеринемии и атеросклероза. Также предложены способы получения этих производных и фармацевтических композиций, содержащих эти производные, их использования в медицине.Quinuclidine derivatives of the indicated formula and their pharmaceutically acceptable salts;
in which R 1 denotes hydrogen or hydroxyl; R 2 is hydrogen or R 1 and R 2 combined together, so that CR 1 - CR 2 denotes a double bond; Ar 1 denotes phenylene; Ar 2 is a 6 membered heteroaryl containing one or two nitrogen atoms; and where one or both of Ar 1 and Ar 2 may optionally contain one or more substituents, such as halogen, hydroxyl, amino, nitro, cyano, carboxyl, carbomoyl, alkyl, alkenyl, alkynyl, alkoxy, alkylamino, dialkylamino, N - alkylcarbamoyl, di-NN-alkylcarbamoyl, alkoxycarbonyl, alkylthio, alkylsulfinyl, alkylsulfonyl, haloalkyl, alkanoylamino, alkylenedioxy, alkanoyl and its oxime derivatives and O-alkyl ethers of the above oxime derivatives; inhibit squalene synthase and therefore suitable for the treatment of diseases and conditions that must be treated, where inhibition of squalene synthase is desirable, for example, for the treatment of hypercholesterolemia and atherosclerosis. Also proposed methods for producing these derivatives and pharmaceutical compositions containing these derivatives, their use in medicine.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9211796.9 | 1992-06-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
RU94015855A true RU94015855A (en) | 1995-11-27 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2263319A1 (en) | Quinazoline derivatives and pharmaceutical compositions containing them | |
CA2242425A1 (en) | Quinazoline derivatives as vegf inhibitors | |
LU91076I9 (en) | 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives | |
CA2258548A1 (en) | Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases | |
DE60017279D1 (en) | Pyrimidinderivate | |
GEP20043324B (en) | Purine Derivatives | |
RU93058555A (en) | Quinuclidine derivatives, a method for their production, a pharmaceutical composition, a method for the treatment or prevention | |
AU2001264474A1 (en) | Admantane derivatives | |
PL342614A1 (en) | Anticarcinogenic drugs | |
IL107287A (en) | Heterocyclic derivatives process for their preparation and pharmaceutical compositions containing some of them | |
FI944823A0 (en) | Galantamine derivatives, method of their preparation and their use in drugs | |
WO1999033450A3 (en) | Pharmaceutical composition containing sibutramine and orlistat | |
DE3686979D1 (en) | CEPHEM CONNECTIONS AND METHOD FOR THEIR PRODUCTION. | |
IL60217A (en) | 4'-deoxyparomomycin derivatives,process for their preparation and pharmaceutical compositions containing them | |
TW276252B (en) | ||
RU94015855A (en) | QUINUCLIDINE DERIVATIVES, METHOD OF THEIR PRODUCTION, PHARMACEUTICAL COMPOSITION | |
BG106180A (en) | Pharmaceutical composition containing sibutramine and orlistat | |
AU3900693A (en) | Quinuclidine derivatives as squalene synthase inhibitors | |
AP9801235A0 (en) | Erythromycin derivatives. | |
AP9901567A0 (en) | Steroids substituted in composition 11, their preparation process, their use as medicaments and the pharmaceutical compounds containing them. | |
CA2392902A1 (en) | Substituted bisindolylmaleimides for the inhibition of cell proliferation | |
RU95112507A (en) | New cephem compounds, process for preparation thereof, method of medical treatment and intermediate products | |
RU93044740A (en) | HETEROCYCLIC COMPOUNDS, METHOD FOR THEIR PRODUCTION, USE AND PHARMACEUTICAL COMPOSITION | |
JO1720B1 (en) | Hetrocyclic derivatives | |
TH25306A (en) | Method of use for inhibition of bone loss and reduction of serum cholesterol. |